Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2018

View Archived Issues

Study gives clues to mitigating pneumonia risk after flu

Structural tuning yields tuberculosis fighter

CRISPR bad news, but with a fix

Crunching the data on CRP

Silencing SOD1 with miRNA for SOD1-linked ALS

New insights into microexon regulation

Fat and fibroblasts

GlycoMimetics initiates phase III trial of uproleselan in relapsed/refractory AML

YC-6 exhibits safety and tolerability in first-in-human study

Deubiquitinase Usp12 is neuroprotective in Huntington's disease neurons

Discovery of new envelope-based antigen that triggers potent humoral responses against HIV-1

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Enesi and Sementis collaborate on solid dose vaccine development

Corcept Therapeutics enrolling participants in phase III study of relacorilant

CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia

Platelet-targeting vaccine may reduce post-stroke blood clot risk

MC-RG19, a novel 5-HT7 receptor antagonist, reduces hypothermia in rats

Upadacitinib demonstrates efficacy in treating ulcerative colitis

Universita di Pisa patents AMPK subunit alpha-2 activators

Novintum Biotechnology presents new doxycycline derivatives for cancer

FDA clears IND for herpes zoster vaccine candidate CRV-101

FDA approves Empliciti plus pomalidomide and dexamethasone for relapsed/refractory multiple myeloma

DSMB recommends discontinuation of phase III study of PREOB for osteonecrosis

Secarna and MetP to codevelop transnasal antisense oligonucleotide-based CNS therapeutics

Sosei collaborates with DyNAbind to accelerate GPCR drug discovery

Tonix presents retrospective analyses from phase III HONOR study of Tonmya in PTSD

BioNTech and University of Pennsylvania collaborate on mRNA-based vaccines for infectious disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...